MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Puri is an accomplished leader and financial sector veteran with over four decades of experience
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
Exploring new opportunities within the fast-growing market of microfluidics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
